BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Pharmacogenetics
,
Lipitor
,
rs6983267
,
EGFR
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Daunorubicin
Summary
General Info
Curated Studies
Most Correlated Studies
Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
B cell lymphoma gene expression in response to the senescence-inducing anti-cancer agent adriamycin
DNA damage in widtype and RORa mutant mice
Breast cancer MCF-7 cells with RBM38 knockdown and doxorubicin induced stress
OV90 sublines selected for resistance to cisplatin, doxorubicin and paclitaxel
Explore Curated Studies Results
Literature
Most Relevant Literature
Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugate…
Spectroscopic, calorimetric and cytotoxicity studies on the combined binding of daunorubicin and acr…
Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy.
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by …
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A pr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ